In a perspective review published in Immunity and Inflammation, a research team led by Cheng Wang, Wanqing Zhou, Liang Li, and Chen-Yu Zhang argues that host-associated microbiology has focused too narrowly on high-biomass barrier-surface communities like the gut. Writing in volume two of the journal, the investigators propose that long-term resident microorganisms occupying internal tissues and circulating host cells represent an underappreciated layer of physiological regulation. Rather than acting purely as dormant bystanders or acute infectious threats, these organisms persist across decades through tightly controlled cellular associations. The authors term this biological category persistent intracellular extraintestinal microbes, introducing human cytomegalovirus as a tractable model to illustrate how enduring intracellular residence tunes basal physiological functions. By moving beyond traditional mucosal boundaries, this conceptual synthesis suggests that internal microorganisms exert durable systemic effects that directly influence how tissues, blood vessels, and immune circuits maintain homeostatic baselines and react to downstream disease triggers.
The authors formally define persistent intracellular extraintestinal microbes as organisms that establish long-term residence within internal tissues or circulating host cells outside classic barrier communities, typically persisting through low-replication or latent states. This classification expressly separates these internal residents from the conventional microbiota populating the digestive tract, skin, and oral cavity, while also distinguishing them from transient mucosal pathogens that never develop stable intracellular niches. According to the framework, the biological significance of these internal microbes does not stem from high biomass, but rather from strategic cellular leverage, specialized tropism, and the continuous modulation of host setpoints. Whereas gut commensals primarily communicate across mucosal interfaces through collective ecological density and large-scale metabolite exchange, internal intracellular microbes reside directly within long-lived host lineages, including immune, endothelial, and stromal compartments. From these vantage points, they gain direct access to host transcriptional machinery, epigenetic programming, and intercellular signaling networks, altering baseline physiological sensitivities without overt symptoms.
Human cytomegalovirus, a beta-herpesvirus with remarkably high global seroprevalence, serves as the central exemplar of this persistent relationship because of its lifelong latency, expansive cellular tropism, and multifaceted repertoire of regulatory macromolecules. In immunocompetent individuals, the virus does not manifest as high-burden disseminated illness, but instead establishes a low-frequency latent reservoir primarily harbored inside CD34-positive hematopoietic progenitor cells, circulating monocytes, and related myeloid-lineage cells. Beyond these specialized blood compartments, human cytomegalovirus infects endothelial cells, fibroblasts, epithelial cells, and stromal niches, situating the viral genome at the crossroads of vascular integrity and host defense. The researchers emphasize that clinical silence within healthy carriers must not be mistaken for biological dormancy. Instead, the persistent virus continuously synthesizes immunomodulatory proteins, regulatory noncoding transcripts, and circulating microRNAs that actively engage host pathways. This enduring intracellular presence establishes a sustained dynamic equilibrium, demonstrating that human cytomegalovirus acts as a continuous state modifier.
A primary mechanism through which human cytomegalovirus tunes host setpoints is the calibration of immune responsiveness, mediated by a redundant suite of specialized viral genes. Viral proteins US2 and US11 drive the dislocation and degradation of HLA class I heavy chains, while US3 retains MHC class I complexes in the endoplasmic reticulum and US6 inhibits TAP-dependent peptide transport. Furthermore, viral infection blunts the maturation of monocytes and dendritic cell precursors, reducing surface expression of CD80, CD83, CD86, and HLA-DR while selectively dampening interleukin-12 production, which alters subsequent T-cell priming dynamics. Concurrently, viral effectors including UL16, UL18, UL40, UL141, and UL148 systematically recalibrate natural killer cell recognition by modulating NKG2D ligands, HLA-E and LIR-1 signaling, and CD58-dependent cytotoxic synapse formation. Host restriction factors, including SAMHD1, reciprocally restrain viral replication to support latency. Over years of host coexistence, this continuous negotiation drives memory inflation, reshapes T-cell pools, and elevates baseline inflammatory tone.
The biological influence of persistent intracellular extraintestinal microbes extends into tissue architecture, vascular dynamics, and regenerative maintenance through active engagement with stromal and endothelial programs. Evidence compiled by the authors demonstrates that human cytomegalovirus localized within vascular tissues directly modulates endothelial barrier integrity, inflammatory signaling, angiogenic responses, and extracellular matrix remodeling. These vascular transformations involve regulated effectors such as Rac1 and VASP signaling pathways, along with matrix metalloproteinase and transforming growth factor-beta regulation, positioning the virus as a modulator of vascular homeostasis. Simultaneously, the virus exerts context-dependent influences over cellular viability, promoting survival in certain infected cells while fostering stress and senescence-like phenotypes in others. These cellular outcomes become especially consequential within regenerative niches, where viral residency inside hematopoietic and mesenchymal stem-cell compartments can alter differentiation trajectories and baseline HLA class I expression. Over time, such subtle adaptations accumulate within aged or chronically inflamed tissues, modifying stromal repair and tissue integrity.
Beyond structural remodeling, human cytomegalovirus rewires cellular metabolic machinery, establishing metabolic shifts that persist beyond acute replication. During productive and persistent states, the virus stimulates glycolysis, redirects carbon toward nucleotide biosynthesis, and orchestrates lipid synthesis through coordinated host enzyme pathways. Mechanistically, viral factor UL38 cooperates with TSC2 and mTOR signaling alongside AMPK activation to accelerate glucose uptake and glycolysis, while sterol regulatory element-binding proteins drive the transcriptional upregulation of key lipogenic enzymes, specifically ACC1 and FASN. Simultaneously, the viral protein pUL37x1 induces calcium-dependent mitochondrial remodeling and stimulates the synthesis of very-long-chain fatty acids, working with altered peroxisomes to meet viral energetic demands. The authors explain that while these enzymatic alterations are frequently categorized as resource scavenging, long-term persistence imposes chronic bioenergetic shifts upon host tissues. By modifying mitochondrial function, oxidative stress, and lipid synthesis, persistent microbes integrate into the host metabolic landscape, potentially influencing diabetes and age-related disorders.
A key mechanism enabling low-biomass intracellular microbes to exert broad systemic influence across distant tissues is intercellular communication. Rather than requiring direct infection of every organ, human cytomegalovirus exports distributed molecular effectors, including proteins, extracellular vesicle cargo, and stable viral microRNAs detected in peripheral circulation. Representative noncoding transcripts, such as hcmv-miR-UL112-3p, hcmv-miR-UL22a-5p, hcmv-miR-US4-1, and miR-US25-1, circulate in human plasma, potentially modulating recipient cells and serving as sensitive readouts of internal viral activity. Furthermore, these microbial signaling outputs intersect bidirectionally with neuroimmune and endocrine communication axes. Inflammatory transcriptional programs involving NF-kappaB and AP-1, alongside pro-inflammatory cytokines and glucocorticoid stress hormones, regulate viral immediate-early gene expression to control latency-reactivation balances. Conversely, persistent viral signaling feeds back into autonomic regulation, vascular inflammatory readiness, and neuroendocrine circuits, linking stress physiology, inflammation, and chronic vascular disorders like hypertension. These circulating effectors illustrate how localized intracellular microbes project functional influence across organ boundaries without high burden.
Pathology arises within this framework when the balance governing regulated persistence breaks down, transitioning into dysregulated persistence and chronic disease. The authors emphasize that host-microbe equilibrium is not a passive stalemate, but an active regulatory state sustained by three layers: host immune surveillance by NK, CD8 T, and myeloid cells; epigenetic and cell-intrinsic silencing of viral lytic promoters; and viral self-limiting immune evasion favoring concealment over replication. However, this equilibrium deteriorates when disrupted by physiological perturbations, including aging, tissue injury, pregnancy, immunosuppression, organ transplantation, intercurrent infections, or elevated glucocorticoid stress signaling. Under these destabilizing pressures, derepression of the viral major immediate-early locus and accelerated myeloid progenitor differentiation expand the active reservoir, shifting the host toward dysregulated persistence. While causality is well established in congenital infection and transplant recipients, the authors note that in immunocompetent individuals, dysregulation manifests across a continuum, transforming a tolerated resident into an amplifier of chronic inflammatory disorders.
The perspective critically evaluates debated links between persistent cytomegalovirus dysregulation and chronic conditions, including autoimmune disorders, cardiovascular disease, and malignancies. Clinical studies report associations with systemic lupus erythematosus and rheumatoid arthritis, whereas findings in Sjogren’s syndrome remain negative or inconsistent. Similarly, although viral components correlate with vascular endothelial dysfunction and plaque pathology, several cardiovascular cohorts fail to demonstrate active disease involvement. In oncology, cytomegalovirus proteins and noncoding RNAs appear within various tumor microenvironments, where viral effectors can modulate proliferation, angiogenesis, and stromal remodeling, yet whether the virus acts as an oncogenic driver, passenger, or cofactor remains unresolved. Intriguingly, the authors propose that circulating viral microRNAs could serve as companion indicators explaining heterogeneous responses to hormone therapy in conditions like menopause multimorbidity, cardiometabolic disease, and hormone-sensitive cancers. Because latent intracellular microbes inhabit endocrine-responsive vascular and stromal niches, monitoring circulating viral RNAs may capture hidden variations in baseline inflammatory and tissue readiness.
To transform this conceptual framework into an experimental discipline, the authors outline an urgent research roadmap designed to move beyond associative cataloging and establish rigorous causal foundations. Future progress requires resolving six formidable obstacles: low microbial biomass creating contamination risks, difficulty distinguishing latent carriage from active transcription, limited access to human tissue reservoirs, and high seroprevalence confounding case-control analyses. Additionally, standardized assays for circulating microbial RNAs and extracellular vesicles remain lacking, alongside a shortage of longitudinal cohorts and perturbation models needed to separate drivers from bystanders. Advanced tools, such as spatially resolved transcriptomics and single-cell multi-omics, will prove essential for identifying rare reservoirs and mapping cellular activity in situ. Ultimately, the authors conclude that expanding microbiome paradigms to incorporate persistent intracellular extraintestinal microbes will reshape our understanding of biological normality, linking virology, immunology, and systems medicine to establish novel biomarker-guided monitoring and therapeutic strategies that preserve lifelong host-microbe equilibrium.
Subject of Research: Persistent intracellular extraintestinal microbes as regulators of host physiological setpoints
Article Title: Beyond the gut microbiome: human cytomegalovirus as a model for persistent intracellular extraintestinal microbes in human homeostasis and disease
Article References: Wang, C., Zhou, W., Li, L., & Zhang, C.-Y. (2026). Beyond the gut microbiome: human cytomegalovirus as a model for persistent intracellular extraintestinal microbes in human homeostasis and disease. Immunity & Inflammation, 2(1), Article 31. https://doi.org/10.1007/s44466-026-00048-y
Image Credits: AI Generated
DOI: 10.1007/s44466-026-00048-y
Keywords: Human cytomegalovirus, Persistent intracellular extraintestinal microbes, Host setpoint tuning, Immune calibration, Viral microRNAs, Latency-reactivation dynamics, Metabolic rewiring, Vascular homeostasis, Hematopoietic progenitor reservoir, Endothelial dysfunction, Extracellular vesicles, Antigen presentation modulation, Major immediate-early locus, Systemic inflammatory tone, Immunosenescence, Host-microbe coexistence, Hormone therapy heterogeneity, Biomarker stratification
Cite Scienmag News
Ophelia Keating. (November 18, 2026). Persistent Intracellular Microbes Beyond The Gut Regulate Human Tissue Setpoints. Scienmag. https://scienmag.com/persistent-intracellular-microbes-beyond-the-gut-regulate-human-tissue-setpoints/
Ophelia Keating. "Persistent Intracellular Microbes Beyond The Gut Regulate Human Tissue Setpoints." Scienmag, 18 November 2026, https://scienmag.com/persistent-intracellular-microbes-beyond-the-gut-regulate-human-tissue-setpoints/. Accessed 18 November 2026.
Ophelia Keating. "Persistent Intracellular Microbes Beyond The Gut Regulate Human Tissue Setpoints." Scienmag. November 18, 2026. https://scienmag.com/persistent-intracellular-microbes-beyond-the-gut-regulate-human-tissue-setpoints/








